Catalyst Wire Dossier Catalyst Wire Dossier

Fufang Biejiaruangan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fufang Biejiaruangan, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]

See pricing